<unk>  is a second-generation H1 receptor antagonist that is indicated mainly for allergic rhinitis and chronic idiopathic urticaria. It is available in 10 and 20 mg tablets and as fast-dissolving tablets, as well as in pediatric syrup. It has a recommended flexible daily dose of 10 or 20 mg, depending on disease severity. Data from over 8,000 patients in more than 40 clinical trials and studies suggest efficacy of<unk>  in the treatment of intermittent allergic rhinitis, persistent allergic rhinitis and other indications.
Ebastine
Clemastine
Azelastine
Pemirolast
Pentagastrin
Altretamine
Hydrastine
Seratrodast